Trials of anti-tuberculosis treatment as a diagnostic tool in smear-negative tuberculosis are of questionable benefit

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 11, 2000, Pages 997-

  Fourie, B ^a   Weyer, K ^a  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT SURVEY; SMEAR;

ALGORITHMS; ANTITUBERCULAR AGENTS; HUMANS; TUBERCULOSIS;

EID: 0033763727     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa
2. Trial-of-antibiotic algorithm for the diagnosis of tuberculosis in a district hospital in a developing country with high HIV prevalence
3. Recurrent tuberculosis: Definitions and treatment regimens